Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Moving beyond cisplatin resistance: mechanisms, challenges, and prospects for overcoming recurrence in clinical cancer therapy
Rui Fu, Borui Zhao, Min Chen, et al.
Medical Oncology (2023) Vol. 41, Iss. 1
Closed Access | Times Cited: 19

Showing 19 citing articles:

Supramolecular nanodrug targeting CDK4/6 overcomes BAG1 mediated cisplatin resistance in oral squamous cell carcinoma
Borui Zhao, Xuan Qin, Rui Fu, et al.
Journal of Controlled Release (2024) Vol. 368, pp. 623-636
Closed Access | Times Cited: 5
Bypassing cisplatin resistance in Nrf2 hyperactivated head and neck cancer through effective PI3Kinase targeting
Pedram Yadollahi, Kelli A. McCord, Yong Li, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2025)
Open Access
Expulsion of iron-rich ferritin via CD63-mediated exosome drives ferroptosis resistance in ovarian cancer cells
Anna Martina Battaglia, Alessandro Sacco, Emanuele Giorgio, et al.
Frontiers in Cell and Developmental Biology (2025) Vol. 13
Open Access
Triple Combinations of Histone Lysine Demethylase Inhibitors with PARP1 Inhibitor–Olaparib and Cisplatin Lead to Enhanced Cytotoxic Effects in Head and Neck Cancer Cells
Dawid Dorna, Robert Kleszcz, Jarosław Paluszczak
Biomedicines (2024) Vol. 12, Iss. 6, pp. 1359-1359
Open Access | Times Cited: 2
Ferroptosis: a novel strategy to overcome chemoresistance in gynecological malignancies
Jing Xu, Bohao Zheng, Wei Wang, et al.
Frontiers in Cell and Developmental Biology (2024) Vol. 12
Open Access | Times Cited: 2
Effects of Reduced Extracellular Sodium Concentrations on Cisplatin Treatment in Human Tumor Cells: The Role of Autophagy
Laura Naldi, Benedetta Fibbi, Cecilia Anceschi, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 8, pp. 4377-4377
Open Access | Times Cited: 1
HEBP2 affects sensitivity to cisplatin and BCNU but not to paclitaxel in MDA-MB-231 breast cancer cells
Hye Rim Kim, Jin‐Kyung Hong, Yongsub Kim, et al.
Toxicological Research (2024) Vol. 40, Iss. 4, pp. 561-569
Closed Access | Times Cited: 1
Shenqi Fuzheng Injection Reduces Cisplatin-Induced Kidney Injury via cGAS/STING Signaling Pathway in Breast Cancer Mice Model
Yingrui Ma, Bufan Bai, Liu Deng, et al.
Breast Cancer Targets and Therapy (2024) Vol. Volume 16, pp. 451-469
Open Access | Times Cited: 1
Cisplatin Resistance and Metabolism: Simplification of Complexity
Nikolay V. Pervushin, Maria A. Yapryntseva, Mikhail A. Panteleev, et al.
Cancers (2024) Vol. 16, Iss. 17, pp. 3082-3082
Open Access | Times Cited: 1
Cisplatin-Induces Kidney Damage through the Down-Regulation of Prx I by Autophagic Degradation
Ji Young Park, Juhyun Sim, Ho Jin Yi, et al.
Free Radical Biology and Medicine (2024)
Open Access | Times Cited: 1
Induction of Ferroptosis by an Amalgam of Extracellular Vesicles and Iron Oxide Nanoparticles Overcomes Cisplatin Resistance in Lung Cancer
Anjugam Paramanantham, Rahmat Asfiya, Yariswamy Manjunath, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access
A Selected Thiosemicarbazone Copper(Ii) Complex Induces Apoptosis in Gastric Cancer and Targets Cancer Stem Cells Reducing Pluripotency Markers
David Fabra, Javier Velazquez Gutierrez, Jorge M. Herrero, et al.
(2024)
Closed Access
Recent status of cisplatin utilization in the treatment of advanced cervical cancer: A bibliometric analysis
Qiang Huang, H Yang, Lin Chen
Asian Journal of Surgery (2024)
Open Access
Platinum(II) triphenylphosphane and triphenylarsane complexes help overcome resistance against cisplatinum resistant cancer cell lines
Lisa Dalla Via, Mariafrancesca Hyeraci, Luca Labella, et al.
Inorganica Chimica Acta (2024), pp. 122396-122396
Open Access
A Select thiosemicarbazone copper(II) complex induces apoptosis in Gastric Cancer and targets Cancer Stem Cells reducing pluripotency markers.
David Fabra, Jorge M. Herrero, Javier Velázquez-Gutiérrez, et al.
European Journal of Medicinal Chemistry (2024) Vol. 280, pp. 116994-116994
Open Access
GULP1 as a Downstream Effector of the Estrogen Receptor-β Modulates Cisplatin Sensitivity in Bladder Cancer
Tomoyuki Tatenuma, Takuo Matsukawa, Takuro Goto, et al.
Cancer Genomics & Proteomics (2024) Vol. 21, Iss. 6, pp. 557-565
Open Access
Recent advances in the development of metallodrugs for cancer chemoimmunotherapy
Fangmian Wei, Jinzhe Liang, Xing‐Can Shen, et al.
Coordination Chemistry Reviews (2024) Vol. 526, pp. 216319-216319
Closed Access
Interactions between ferroptosis and tumour development mechanisms: Implications for gynaecological cancer therapy (Review)
Peng Wu, Jianlin Chen, Hui Li, et al.
Oncology Reports (2024) Vol. 53, Iss. 2
Open Access
Exosomal miR-130a-3p confers cisplatin resistance in esophageal cancer by regulating ferroptosis via the suppression of METTL14-mediated m6A RNA methylation of FSP1
Hu Han, Yan Li, Zhiyi Lin, et al.
International Immunopharmacology (2024) Vol. 146, pp. 113804-113804
Closed Access
Endoplasmic reticulum stress-MMRN1 positive feedback contributes to cisplatin resistance in small cell lung cancer
Mingxin Liu, Peihong Hu, Bo Tang, et al.
Journal of Thoracic Disease (2024) Vol. 16, Iss. 12, pp. 8363-8378
Open Access
Page 1

Scroll to top